158 related articles for article (PubMed ID: 34324022)
41. A TP53-based immune prognostic model for muscle-invasive bladder cancer.
Li H; Lu H; Cui W; Huang Y; Jin X
Aging (Albany NY); 2020 Dec; 13(2):1929-1946. PubMed ID: 33323544
[TBL] [Abstract][Full Text] [Related]
42. Emerging immune checkpoints for cancer therapy.
Li X; Hu W; Zheng X; Zhang C; Du P; Zheng Z; Yang Y; Wu J; Ji M; Jiang J; Wu C
Acta Oncol; 2015 Nov; 54(10):1706-13. PubMed ID: 26361073
[TBL] [Abstract][Full Text] [Related]
43. Differential expression pattern of co-inhibitory molecules on CD4
Abel A; Steeg C; Aminkiah F; Addai-Mensah O; Addo M; Gagliani N; Casar C; Yar DD; Owusu-Dabo E; Jacobs T; Mackroth MS
Sci Rep; 2018 Mar; 8(1):4789. PubMed ID: 29555909
[TBL] [Abstract][Full Text] [Related]
44. A molecular signature for CD8
Singh B; Bhushan Chauhan S; Kumar R; Singh SS; Ng S; Amante F; de Labastida Rivera F; Singh OP; Rai M; Nylen S; Sundar S; Engwerda C
Parasite Immunol; 2019 Nov; 41(11):e12669. PubMed ID: 31494954
[TBL] [Abstract][Full Text] [Related]
45. CD8
Lukas Yani S; Keller M; Melzer FL; Weinberger B; Pangrazzi L; Sopper S; Trieb K; Lobina M; Orrù V; Fiorillo E; Cucca F; Grubeck-Loebenstein B
Front Immunol; 2018; 9():1201. PubMed ID: 29915580
[TBL] [Abstract][Full Text] [Related]
46. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
47. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
48. Expression of the checkpoint receptors LAG-3, TIM-3 and VISTA in peripheral T cell lymphomas.
Murga-Zamalloa CA; Brown NA; Wilcox RA
J Clin Pathol; 2020 Apr; 73(4):197-203. PubMed ID: 31672704
[TBL] [Abstract][Full Text] [Related]
49. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
50. -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
Oliveira VB; Dezan MR; Gomes FCA; Menosi Gualandro SF; Krieger JE; Pereira AC; Marsiglia JD; Levi JE; Rocha V; Mendrone-Junior A; Sabino EC; Dinardo CL
Int J Immunogenet; 2017 Oct; 44(5):219-224. PubMed ID: 28815969
[TBL] [Abstract][Full Text] [Related]
51. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
Al-Badran SS; Grant L; Campo MV; Inthagard J; Pennel K; Quinn J; Konanahalli P; Hayman L; Horgan PG; McMillan DC; Roxburgh CS; Roseweir A; Park JH; Edwards J
J Pathol Clin Res; 2021 Mar; 7(2):121-134. PubMed ID: 33338327
[TBL] [Abstract][Full Text] [Related]
52. Combination Immune Checkpoint Blockade to Reverse HIV Latency.
Van der Sluis RM; Kumar NA; Pascoe RD; Zerbato JM; Evans VA; Dantanarayana AI; Anderson JL; Sékaly RP; Fromentin R; Chomont N; Cameron PU; Lewin SR
J Immunol; 2020 Mar; 204(5):1242-1254. PubMed ID: 31988180
[TBL] [Abstract][Full Text] [Related]
53. Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia.
Yan L; Fu R; Liu H; Wang H; Liu C; Wang T; Qi W; Guan J; Li L; Shao Z
Cell Immunol; 2015 Aug; 296(2):95-105. PubMed ID: 25906694
[TBL] [Abstract][Full Text] [Related]
54. Role of Regulatory T Cells and Inhibitory Molecules in the Development of Immune Exhaustion During Human Immunodeficiency Virus Type 1 Infection.
Gonzalez SM; Zapata W; Rugeles MT
Viral Immunol; 2016; 29(1):2-10. PubMed ID: 26566019
[TBL] [Abstract][Full Text] [Related]
55. Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade.
Grabmeier-Pfistershammer K; Stecher C; Zettl M; Rosskopf S; Rieger A; Zlabinger GJ; Steinberger P
Clin Immunol; 2017 Oct; 183():167-173. PubMed ID: 28882621
[TBL] [Abstract][Full Text] [Related]
56. Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.
Datar I; Sanmamed MF; Wang J; Henick BS; Choi J; Badri T; Dong W; Mani N; Toki M; Mejías LD; Lozano MD; Perez-Gracia JL; Velcheti V; Hellmann MD; Gainor JF; McEachern K; Jenkins D; Syrigos K; Politi K; Gettinger S; Rimm DL; Herbst RS; Melero I; Chen L; Schalper KA
Clin Cancer Res; 2019 Aug; 25(15):4663-4673. PubMed ID: 31053602
[TBL] [Abstract][Full Text] [Related]
57. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.
Anderson AC; Joller N; Kuchroo VK
Immunity; 2016 May; 44(5):989-1004. PubMed ID: 27192565
[TBL] [Abstract][Full Text] [Related]
58. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
[TBL] [Abstract][Full Text] [Related]
59. CTLA-4 and HLA-DQ are key molecules in the regulation of mDC-mediated cellular immunity by Tregs in severe aplastic anemia.
Liu B; Shao Y; Liang X; Lu D; Yan L; Churov A; Fu R
J Clin Lab Anal; 2020 Oct; 34(10):e23443. PubMed ID: 32621335
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy.
Motavalli R; Hosseini M; Soltani-Zangbar MS; Karimi A; Sadeghi M; Dolati S; Yousefi M; Etemadi J
Mol Cell Probes; 2023 Jun; 69():101914. PubMed ID: 37075987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
